🇺🇸 Sodium Bicarbonate Tablets in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 12

Most-reported reactions

1. Atrial Fibrillation — 2 reports (16.67%)
2. Platelet Count Decreased — 2 reports (16.67%)
3. Anaemia — 1 report (8.33%)
4. Arrhythmia — 1 report (8.33%)
5. Atrioventricular Block First Degree — 1 report (8.33%)
6. Blood Calcium Decreased — 1 report (8.33%)
7. Blood Creatinine Increased — 1 report (8.33%)
8. Blood Glucose Increased — 1 report (8.33%)
9. Blood Pressure Decreased — 1 report (8.33%)
10. Blood Sodium Decreased — 1 report (8.33%)

Source database →

Frequently asked questions

Is Sodium Bicarbonate Tablets approved in United States?

Sodium Bicarbonate Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Sodium Bicarbonate Tablets in United States?

University of Colorado, Denver is the originator. The local marketing authorisation holder may differ — check the official source linked above.